Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2013 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Exchange Rate Effect of $6000.0 for Q1 2026, up 166.67% year-over-year from $2250.0 in Q1 2025, and up 142.86% quarter-over-quarter from -$14000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Exchange Rate Effect history runs 14 years deep, the most recent figure standing at $6000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 166.67% year-over-year to $6000.0; the TTM figure through Mar 2026 stood at -$16000.0 (down 1500.0% YoY), while the FY2025 annual figure was -$31000.0, down 875.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $6000.0, up from -$14000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $24000.0 in Q4 2024, with the low at -$43000.0 in Q1 2023.
- The 5-year median for Exchange Rate Effect is -$9500.0 (2023), against an average of -$10000.0.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect slumped 2400.0% in 2022, then jumped 340.0% in 2024.
- Tonix Pharmaceuticals Holding's Exchange Rate Effect stood at -$5000.0 in 2022, then sank by 100.0% to -$10000.0 in 2023, then soared by 340.0% to $24000.0 in 2024, then sank by 158.33% to -$14000.0 in 2025, then surged by 142.86% to $6000.0 in 2026.
- Business Quant data shows TNXP's Exchange Rate Effect at $6000.0 in Q1 2026, -$14000.0 in Q4 2025, and -$4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -64,000.00 |
| Jun 30, 2026 | -64,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |